- Home
- FMBH vs YDES Comparison
FMBH vs YDES Comparison
Compare FMBH & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | FMBH | YDES |
|---|---|---|
| Founded | 1865 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 951.4M | 894.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FMBH | YDES |
|---|---|---|
| Price | $43.25 | $9.91 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $43.40 | N/A |
| AVG Volume (30 Days) | ★ 118.4K | 37.5K |
| Earning Date | 01-29-2026 | 03-30-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 3.83 | N/A |
| Revenue | ★ $339,295,000.00 | $510,360.00 |
| Revenue This Year | $8.91 | N/A |
| Revenue Next Year | $6.82 | N/A |
| P/E Ratio | $11.30 | ★ N/A |
| Revenue Growth | 6.24 | ★ 45.76 |
| 52 Week Low | $27.58 | $5.30 |
| 52 Week High | $44.85 | $31.00 |
Technical Indicators
Market Signals| Indicator | FMBH | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 52.61 | 35.83 |
| Support Level | $42.05 | $9.76 |
| Resistance Level | $44.84 | $11.80 |
| Average True Range (ATR) | 1.16 | 0.75 |
| MACD | -0.13 | -0.15 |
| Stochastic Oscillator | 47.51 | 5.79 |
Price Performance
Historical ComparisonAbout FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.